{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:09:56Z","timestamp":1761512996467},"reference-count":15,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.clinthera.2011.05.045","type":"journal-article","created":{"date-parts":[[2011,6,26]],"date-time":"2011-06-26T05:01:28Z","timestamp":1309064488000},"page":"746-753","source":"Crossref","is-referenced-by-count":8,"title":["Steady-State Pharmacokinetics of Once-Daily Cyclobenzaprine Extended Release: A Randomized, Double-Blind, 2-Period Crossover Study in Healthy Volunteers"],"prefix":"10.1016","volume":"33","author":[{"given":"Mona","family":"Darwish","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward T.","family":"Hellriegel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2011.05.045_bib1","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/S0149-2918(03)80067-X","article-title":"Efficacy of a low-dose regimen of cyclobenzaprine hydrochloride in acute skeletal muscle spasm: results of two placebo-controlled trials","volume":"25","author":"Borenstein","year":"2003","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2011.05.045_bib2","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1001\/archinte.161.13.1613","article-title":"Cyclobenzaprine and back pain: a meta-analysis","volume":"161","author":"Browning","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.clinthera.2011.05.045_bib3","first-page":"409","article-title":"Cyclobenzaprine, diazepam and placebo in the treatment of skeletal muscle spasm of local origin","volume":"1","author":"Nibbelink","year":"1978","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2011.05.045_bib4","first-page":"216","article-title":"Cyclobenzaprine in the treatment of acute muscle spasm: review of a decade of clinical experience","volume":"10","author":"Katz","year":"1988","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2011.05.045_bib5","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1185\/03007990902851753","article-title":"Cyclobenzaprine ER for muscle spasm associated with low back and neck pain: two randomized, double-blind, placebo-controlled studies of identical design","volume":"25","author":"Malanga","year":"2009","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.clinthera.2011.05.045_bib6","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1177\/0091270002042001007","article-title":"Cyclobenzaprine pharmacokinetics, including the effects of age, gender, and hepatic insufficiency","volume":"42","author":"Winchell","year":"2002","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2011.05.045_bib7","first-page":"894","article-title":"Cyclobenzaprine (Flexeril\u2122): report of a postmarketing surveillance program","volume":"28","author":"Nibbelink","year":"1980","journal-title":"Curr Ther Res"},{"key":"10.1016\/j.clinthera.2011.05.045_bib8","doi-asserted-by":"crossref","first-page":"793","DOI":"10.2165\/0044011-200828120-00007","article-title":"Single-dose pharmacokinetics of once-daily cyclobenzaprine extended release 30 mg versus cyclobenzaprine immediate release 10 mg three times daily in healthy young adults: a randomized, open-label, two-period crossover, single-centre study","volume":"28","author":"Darwish","year":"2008","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.clinthera.2011.05.045_bib9","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2165\/0002512-200926020-00001","article-title":"Comparison of the single-dose pharmacokinetics of once-daily cyclobenzaprine extended-release 30 mg and cyclobenzaprine immediate-release 10 mg three times daily in the elderly: a randomized, open-label, crossover study","volume":"26","author":"Darwish","year":"2009","journal-title":"Drugs Aging"},{"key":"10.1016\/j.clinthera.2011.05.045_bib10","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.clinthera.2009.01.014","article-title":"A pharmacokinetic comparison of single doses of once-daily cyclobenzaprine extended-release 15 mg and 30 mg: a randomized, double-blind, two-period crossover study in healthy volunteers","volume":"31","author":"Darwish","year":"2009","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2011.05.045_bib11","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2165\/00044011-200929030-00001","article-title":"Effect of food on the pharmacokinetics of once-daily cyclobenzaprine extended-release 30 mg: a randomized, open-label, crossover, single-centre study","volume":"29","author":"Darwish","year":"2009","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.clinthera.2011.05.045_bib14","first-page":"264","article-title":"Design and Analysis of Clinical Experiments","author":"Fleiss","year":"1986"},{"key":"10.1016\/j.clinthera.2011.05.045_bib15","series-title":"Pharmaceutical Statistics: Practical and Clinical Applications","author":"Bolton","year":"1997"},{"key":"10.1016\/j.clinthera.2011.05.045_bib16","doi-asserted-by":"crossref","first-page":"158","DOI":"10.3810\/pgm.2010.07.2182","article-title":"Efficacy and tolerability of cyclobenzaprine extended release for acute muscle spasm: a pooled analysis","volume":"122","author":"Weil","year":"2010","journal-title":"Postgrad Med"},{"key":"10.1016\/j.clinthera.2011.05.045_bib17","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/bdd.2510030104","article-title":"Evidence for route dependent biotransformation of cyclobenzaprine hydrochloride","volume":"3","author":"Till","year":"1982","journal-title":"Biopharm Drug Dispos"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291811002815?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291811002815?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T17:23:54Z","timestamp":1543685034000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291811002815"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S0149291811002815"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2011.05.045","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]}}}